GlobeNewswire Inc.··Researchandmarkets.ComDysport Eyes $11.3B Market as Botox Rival Gains Ground Through 2034
Ipsen's Dysport projects strong growth in aesthetic injectables, holding 12% market share against Botox's 72% across seven major global markets through 2034.
GALDYIPSEYmarket forecastcompetitive pricing